Business
Nautilus Biotechnology Launches Early Access Program for Novel Single-Molecule Proteomics Platform, Starting with Tau Proteoforms Assay
Early Access Program participants receive exclusive use of Nautilus’ Iterative Mapping method, initially through a validated tau proteoforms assay, with the potential to accelerate Alzheimer’s and neurodegenerative disease researchSEATTLE, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering single-molecule proteome analysis, today announced the launch of an Early Access Program for its novel proteomics platform, with a tau proteoform
About this update from Nautilus Biotechnology, Inc.
[{"type":"image","alt":"Nautilus Biotechnology Inc.","displaySize":"","headline":null,"caption":"Nautilus Biotechnology Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":95,"url":"https://media.zenfs.com/en/globenewswire.com/22bec2aa5e570b0579f33fbb9cc54864"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/gZG4ft0bTsyv782wsqtQmA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEzMztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/22bec2aa5e570b0579f33fbb9cc54864","width":300,"height":95}},"lazy":false},{"type":"text","content":"Early Access Program participants receive exclusive use of Nautilus’ Iterative Mapping method, initially through a validated tau proteoforms assay, with the potential to accelerate Alzheimer’s and neurodegenerative disease research","length":231,"tagName":"p"},{"type":"text","content":"SEATTLE, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering single-molecule proteome analysis, today announced the launch of an Early Access Program for its novel proteomics platform, with a tau proteoforms assay as its first offering. The program makes Nautilus' Iterative Mapping approach to measuring proteins and their variants available to an exclusive group of researchers.","length":447,"tagName":"p"},{"type":"text","content":"Nautilus’ Iterative Mapping method enables single-molecule analysis of proteins and proteoforms and is designed to achieve comprehensive proteome coverage and detail at scale. The method empowers researchers to precisely map combinatorial patterns of post-translational modifications on individual proteins and study how those patterns evolve over the course of diseases such as Alzheimer’s and other neurodegenerative disorders. This high level of resolution makes it possible to uncover biological insights that are difficult or impossible to obtain with conventional proteomics approaches such as traditional affinity-based methods and mass spectrometry.","length":657,"tagName":"p"},{"type":"text","content":"The Early Access Program represents a key milestone in Nautilus’ path to commercialization, demonstrating the platform’s expected readiness for external use as the company advances capabilities in the future, including additional targeted proteoform analyses, broadscale proteomics, and beyond. Participants will receive su...